- €1.08bn
- €1.68bn
- €1.29bn
- 57
- 42
- 96
- 75
Annual income statement for Terveystalo Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,031 | 986 | 1,155 | 1,259 | 1,286 |
| Cost of Revenue | |||||
| Gross Profit | 998 | 952 | 1,119 | 1,215 | 1,246 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 949 | 919 | 1,045 | 1,225 | 1,301 |
| Operating Profit | 81.4 | 67.2 | 110 | 33.9 | -14.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 66.8 | 56.6 | 101 | 30.9 | -38.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 54.2 | 45.8 | 80.4 | 24.4 | -42.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 54.3 | 45.8 | 80.4 | 24.4 | -42.2 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 54.2 | 45.8 | 80.5 | 24.4 | -42.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.461 | 0.387 | 0.666 | 0.637 | 0.228 |
| Dividends per Share |